Investors Buy Shares of Becton Dickinson and (BDX) on Weakness

Investors bought shares of Becton Dickinson and Co (NYSE:BDX) on weakness during trading hours on Thursday. $86.30 million flowed into the stock on the tick-up and $54.04 million flowed out of the stock on the tick-down, for a money net flow of $32.26 million into the stock. Of all stocks tracked, Becton Dickinson and had the 30th highest net in-flow for the day. Becton Dickinson and traded down ($0.17) for the day and closed at $218.77

Several brokerages recently weighed in on BDX. Argus lifted their price objective on shares of Becton Dickinson and to $235.00 and gave the company a “buy” rating in a research report on Thursday. They noted that the move was a valuation call. Stifel Nicolaus reiterated a “buy” rating and issued a $245.00 price objective on shares of Becton Dickinson and in a research report on Friday, November 3rd. Morgan Stanley lifted their price objective on shares of Becton Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $230.00 price objective (up from $210.00) on shares of Becton Dickinson and in a research report on Friday, November 3rd. Finally, Zacks Investment Research upgraded shares of Becton Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 price objective on the stock in a research report on Tuesday, October 31st. Four investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $218.36.

The stock has a market capitalization of $49,874.81, a PE ratio of 23.05, a P/E/G ratio of 1.71 and a beta of 1.07. The company has a quick ratio of 5.03, a current ratio of 5.58 and a debt-to-equity ratio of 1.44.

Becton Dickinson and (NYSE:BDX) last released its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $2.37 by $0.03. Becton Dickinson and had a net margin of 8.52% and a return on equity of 20.56%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.14 billion. During the same period in the previous year, the firm earned $2.12 EPS. Becton Dickinson and’s revenue was down 2.0% on a year-over-year basis. sell-side analysts forecast that Becton Dickinson and Co will post 10.63 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 8th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. This is an increase from Becton Dickinson and’s previous quarterly dividend of $0.73. The ex-dividend date of this dividend is Thursday, December 7th. Becton Dickinson and’s payout ratio is 64.52%.

Several hedge funds have recently added to or reduced their stakes in BDX. Family Firm Inc. raised its holdings in shares of Becton Dickinson and by 0.5% in the 2nd quarter. Family Firm Inc. now owns 1,212 shares of the medical instruments supplier’s stock worth $236,000 after purchasing an additional 6 shares in the last quarter. Northwest Quadrant Wealth Management LLC raised its holdings in shares of Becton Dickinson and by 0.4% in the 2nd quarter. Northwest Quadrant Wealth Management LLC now owns 1,686 shares of the medical instruments supplier’s stock worth $332,000 after purchasing an additional 6 shares in the last quarter. Northstar Group Inc. raised its holdings in shares of Becton Dickinson and by 0.3% in the 2nd quarter. Northstar Group Inc. now owns 2,994 shares of the medical instruments supplier’s stock worth $584,000 after purchasing an additional 9 shares in the last quarter. NBT Bank N A NY raised its holdings in shares of Becton Dickinson and by 0.3% in the 2nd quarter. NBT Bank N A NY now owns 3,351 shares of the medical instruments supplier’s stock worth $654,000 after purchasing an additional 10 shares in the last quarter. Finally, Good Life Advisors LLC raised its holdings in shares of Becton Dickinson and by 0.6% in the 2nd quarter. Good Life Advisors LLC now owns 2,494 shares of the medical instruments supplier’s stock worth $491,000 after purchasing an additional 14 shares in the last quarter. Institutional investors own 88.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/16/investors-buy-shares-of-becton-dickinson-and-bdx-on-weakness.html.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply